Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

SLNO Soleno Therapeutics Inc

41,16

-0,01 (-0,02%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:02:29

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Soleno Therapeutics Charts.

Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Soleno Therapeutics Charts.

News Soleno Therapeutics Inc

Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
Mittwoch 22 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Soleno Therapeutics to Participate in Upcoming Investor Conferences
Mittwoch 22 Mai 2024 (2 Tage vor) • GlobeNewswire Inc.

Soleno Therapeutics Stands with the Prader-Willi Syndrome Community
Mittwoch 15 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 9 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
Donnerstag 9 Mai 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 7 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Montag 6 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock
Freitag 3 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Soleno Therapeutics Announces Proposed Public Offering of Common Stock
Donnerstag 2 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

Soleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi Syndrome
Dienstag 30 April 2024 (3 Wochen vor) • GlobeNewswire Inc.

Soleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)
Montag 29 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 19 April 2024 (1 Monat vor) • GlobeNewswire Inc.

Weitere Soleno Therapeutics Inc News-Artikel

NLBNPIT1ZY60 20351221 80...

Blue Star Foods

NLBNPIT20EC9 20351221 91...

NLBNPIT1T7P3 20240621 2300

NLBNPIT20ZM3 20250620 39...

NLBNPIT20YI4 20240621 5.5

NLBNPIT1W0X7 20991231 17...

NLBNPIT21A90 20991231 31...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen